New hope for depression? capsule trial seeks to ease symptoms
Symptom relief
Recruiting now
This study is testing an investigational capsule called TJ0113 to see if it can safely reduce symptoms of depression. About 150 adults with moderate to severe depression will take either TJ0113 at one of two doses or a placebo pill daily for 8 weeks. Researchers will measure chan…
Phase: PHASE2 • Sponsor: Hangzhou PhecdaMed Co., Ltd. • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC